These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20170869)
21. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Rossini R; Capodanno D; Lettieri C; Musumeci G; Nijaradze T; Romano M; Lortkipanidze N; Cicorella N; Biondi Zoccai G; Sirbu V; Izzo A; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ Am J Cardiol; 2011 Jan; 107(2):186-94. PubMed ID: 21211596 [TBL] [Abstract][Full Text] [Related]
22. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
23. Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents. Singh T; Cuomo L; Cohen M; Ahmad HA; Aronow WS Curr Clin Pharmacol; 2013 Feb; 8(1):59-66. PubMed ID: 22946865 [TBL] [Abstract][Full Text] [Related]
24. Stents and antiplatelet therapy. Fassa AA; Urban P Adv Cardiol; 2012; 47():114-24. PubMed ID: 22906907 [TBL] [Abstract][Full Text] [Related]
25. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
26. Status of drug-eluting coronary stents. Chodosh A; Korr KS; Burtt D Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106 [TBL] [Abstract][Full Text] [Related]
27. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials). Lee SW; Lee JY; Ahn JM; Park DW; Han S; Park YK; Lee WS; Jang JY; Kwon CH; Park GM; Cho YR; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ Am J Cardiol; 2013 Dec; 112(11):1738-44. PubMed ID: 24063835 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Tanzilli G; Greco C; Pelliccia F; Pasceri V; BarillĂ F; Paravati V; Pannitteri G; Gaudio C; Mangieri E Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050 [TBL] [Abstract][Full Text] [Related]
29. Long-term safety of drug-eluting stents. Riede FN; Pfisterer M; Jeger R Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1359-78. PubMed ID: 24138523 [TBL] [Abstract][Full Text] [Related]
30. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Yan BP; Gurvitch R; Ajani AE Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822 [TBL] [Abstract][Full Text] [Related]
31. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228 [TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961 [TBL] [Abstract][Full Text] [Related]
33. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies. Mohammad RA; Goldberg T; Dorsch MP; Cheng JW Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100 [TBL] [Abstract][Full Text] [Related]
34. Perioperative management of the patient with a coronary stent. Popescu WM Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828 [TBL] [Abstract][Full Text] [Related]
35. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature. Lemesle G; Paparoni F; Delhaye C; Bonello L; Lablanche JM Hosp Pract (1995); 2011 Oct; 39(4):32-40. PubMed ID: 22056821 [TBL] [Abstract][Full Text] [Related]
36. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Chhatriwalla AK; Bhatt DL Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681 [No Abstract] [Full Text] [Related]
37. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. Dangas GD; Claessen BE; Mehran R; Xu K; Stone GW EuroIntervention; 2013 Jan; 8(9):1033-9. PubMed ID: 23339809 [TBL] [Abstract][Full Text] [Related]
38. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. Paradis JM; Ducrocq G; Tanguay JF Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176 [TBL] [Abstract][Full Text] [Related]
39. Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. Rogacka R; Chieffo A; Michev I; Airoldi F; Latib A; Cosgrave J; Montorfano M; Carlino M; Sangiorgi GM; Castelli A; Godino C; Magni V; Aranzulla TC; Romagnoli E; Colombo A JACC Cardiovasc Interv; 2008 Feb; 1(1):56-61. PubMed ID: 19393145 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous left anterior descending and right coronary stent thrombosis after aspirin withdrawal. Omar HR; Mangar D; Karlnoski R; Abdelmalak HD; Camporesi EM Am J Emerg Med; 2012 Nov; 30(9):2093.e5-8. PubMed ID: 22386339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]